Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presen

[News]

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS).

More... (http://www.news-medical.net/news/20091214/Results-from-Phase-2-trial-evaluating-Nexavar-with-capecitabine-and-paclitaxel-presented.aspx)